Geode Capital Management, LLC Dice Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$25.86 - $46.71 $1.23 Million - $2.21 Million	47,408 Added 6.81%	743,341 $34.5 Million
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $758,237 - $940,447	29,107 Added 4.37%	695,933 $19.9 Million
Q4 2022 Feb 13, 2023	BUY	$19.77 - $42.23 $3.6 Million - $7.7 Million	182,224 Added 37.6%	666,826 $20.8 Million
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $1.55 Million - $2.35 Million	103,557 Added 27.18%	484,602 $9.83 Million
Q2 2022 Aug 12, 2022	BUY	$13.19 - $22.1 $1.84 Million - $3.07 Million	139,135 Added 57.52%	381,045 $5.91 Million
Q1 2022 May 13, 2022	BUY	$14.54 - $25.02 $901 - $1,551	62 Added 0.03%	241,910 $4.63 Million
Q4 2021 Feb 11, 2022	BUY	$22.41 - $37.54 $5.42 Million - $9.08 Million	241,848 New	241,848 $6.12 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.